How effective are PDE-5 inhibitors?;Wie wirksam sind die PDE-5-Hemmstoffe?

Urologe - Ausgabe A

Volumn 42, Issue 4, 2003, Pages 553-558

  Junemann K P ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Erectile dysfunction; Sildenafil; Tadalafil; Therapy; Vardenafil

Indexed keywords

NEW DRUG; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; VARDENAFIL;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; MALE; MULTICENTER STUDY; PATIENT COUNSELING; PATIENT INFORMATION; PATIENT SATISFACTION; REVIEW; STANDARD; TREATMENT FAILURE;

EID: 0037937600     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0331-6     Document Type: Review

References (20)

1. Boulton AJM, Selam JL, Sweeney M, Ziegler D (2001) Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 44: 1296-1301
2. Braun M, Klotz T, Reifenrath B, Wassmer G, Engelmann U (1998) "KEED" - erster deutschsprachig validierter Fragebogen zur Erfassung der männlichen sexuellen Funktion. Akt Urol 29: 300-305
3. Brock G, Iglesias J, Toulouse K et al. (2001) Efficacy and safety of tadalafil (IC3S1) treatment for ED. (Vorgestellt auf dem 16th Congress of the European Association of Urology (EAU), Genf, 7.-10. April 2001)
4. Carson CC (2002) Patients and physicians speek up: uncovering current issues. (Vortrag auf dem CME Symposium "Erectile dysfunction: eludicating the issues andenhancing sexual health" im Rahmen der 97. Jahrestagung der American Urological Associatio, Orlando, Florida, 24. Mai 2002)
5. Erdogru T, Usta MF, Çeken K et al. (2002) Is sildenafil citrate an alternative agent in the evaluation of penile vascular system with color Doppler ultrasound. Urol Int 68: 255-260
6. Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ (2002) Sildenafil for male erectile dysfunction. A systematic review and meta-analysis. Arch Intern Med 162: 1349-1360
7. Goldstein I, Lue T, Padma-Nathan H, Rosen R, Steers W, Wicker P for the Sildenafil Study Group (1998) Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338: 1397-1404
8. Goldstein I, Young JM, Fischer Jet al. (2001) Vardenafil, a new highly selective PDES inhibitor, improves erectile dysfunction in patients with diabetes mellitus. (Vorgestellt auf der 61 st Scientific Sessions of the American Diabetes Association, Philadelphia, 22.-26. Juni 2001)
9. Hanson-Divers C, Jackson SE, Lue TF, Crawford SY, Rosen RC (1998) Health outcomes variables important to patients in the treatment of erectile dysfunction. J Urol 159: 1541-1547
10. Hellstrom WJ, Gittelman M, Karlin G et al. (2002) Efficacy and safety of vardenafil in men with erectile dysfunction: the North American (NA) pivotal placebocontrolled trial. (Vorgestellt auf der 97. Jahrestagung der American Urological Associatio, Orlando, Florida, 25.-29. Mai 2002)
11. Jünemann KP (1998) SDN-D-98-002: Studie zur Beurteilung der Therapiezufriedenheit mit dem Behandlungsergebnis nach Therapie mit Viagra®. (Unveröffentlicht)
12. Montorsi F, McDermott TED, Morgan R et al. (1999) Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 53: 1011-1018
13. Padma-Nathan H, McMurray JG, Pullman WE, Whitaker JS, Ferguson KM, Rosen RC for the IC3S1 on-demand dosing study group (2001). Int J Impot Res 13: 2-9
14. Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, Bandel T and the Vardenafil Study Group (2001) The efficacy and tolerability of vardenafil, a new, oral, selective phosphsdiesterase type S inhibitor, in patients with erectile dysfunction: first at-home clinical trial. Int J Impot Res 13: 192-199
15. Rendell M, Rajfer J, Wicker P, Smith M for the Sildenafil Diabetes Study Group (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized control trial. JAMA 281: 421-426
16. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, S-item version of the international Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11: 319-326
17. Rosen RC, Riley A, Wagner G et al. (1997) The International Index of Erectile Dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49: 822-830
18. Sáenz de Tejada I, Emmick J, Anglin G, Fredlund P, Pullman W (2001) The effect of as-needed tadalafil (IC3S1) treatment of erectile dysfunction in men with diabetes. (Vorgestellt auf dem 4th Congress of the European Society for sexual and Impotence Research (ESSIR), Rom, 30.9.-3.10.2001)
19. Sweeney M, Cappelleri JC, Rosen RC, Smith MD, Mishra A (1999) A diagnostic evaluation of the erectile function domain of the International Index of Erectile Dysfunction (IIEF). (Vorgestellt auf der 1st International Consultation on Erectile Dysfunction, Paris, 1.-3. Juli 1999)
20. US Food and Drug Administration/Center for Drug Evaluation and Research (1998) Viagra information. http://www.fda.gov/cder/consumerinfo/viagra/default.htm